The Integrated Research Facility at Fort Detrick in Frederick, Maryland, (IRF-Frederick) is part of the Office of the Chief Scientist for the Division of Clinical Research (DCR) in the NIAID Office of the Director.
The mission of the OCSIRF is to manage, coordinate, and facilitate the conduct of emerging infectious disease and biodefense research to develop vaccines, countermeasures, and improved medical outcomes for patients.
To accomplish the mission, highly trained scientists working at the IRF-Frederick collaborate with internal (NIAID) and extramural investigators to conduct research on viruses, such as those causing high-consequence disease (e.g., Ebola and SARS-CoV-2) and many other viruses included on the NIAID Priority Pathogens list.
The IRF-Frederick has the capability to conduct biosafety level (BSL)-2 , BSL‑3, and BSL-4 research. It is one of the few facilities in the world able to perform whole-body and other medical imaging to evaluate infection of animals in BSL-4 containment. These unique features enable the comparison of various exposure routes for either naturally occurring or deliberately released viral pathogens.